Search Results - "Kedir, Hanan Muzeyin"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Pharmacy professionals’ knowledge, attitude and practice towards doping in sports: A Cross-sectional study in Ethiopia by Kedir, Hanan Muzeyin, Kemal, Hassen Seid, Mekonen, Zelalem Tilahun, Huluka, Solomon Assefa, Abiye, Alfoalem Araba

    Published in Heliyon (01-11-2023)
    “…Doping is appearing as a major problem in Ethiopia, a country decorated with medium and long-distance runners. To protect athletes from doping, pharmacists can…”
    Get full text
    Journal Article
  2. 2

    Incidence of thromboembolism and thromboprophylaxis in medical patients admitted to specialized hospital in Ethiopia using Padua prediction score by Asmamaw, Mulugeta, Hungnaw, Wubet, Motbainor, Achenef, Kedir, Hanan Muzeyin, Tadesse, Tamrat Assefa

    Published in SAGE open medicine (01-02-2022)
    “…Introduction: Venous thromboembolism is a major cause of mortality and morbidity among hospitalized patients and thromboprophylaxis is one of the key…”
    Get full text
    Journal Article
  3. 3

    Comparison of Aspirin and Rivaroxaban Plus Aspirin in the Management of Stable Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomized Controlled Trials by Debasu, Zenaw, Kedir, Hanan Muzeyin, Tadesse, Tamrat Assefa

    Published in International journal of general medicine (30-09-2022)
    “…Introduction: Low-dose aspirin or clopidogrel, statins, renin-angiotensin system inhibitors, and beta blockers are the cornerstone therapy for cardiovascular…”
    Get full text
    Journal Article
  4. 4

    Venous Thromboembolism Risk and Thromboprophylaxis Assessment in Surgical Patients Based on Caprini Risk Assessment Model by Tadesse, Tamrat Assefa, Kedir, Hanan Muzeyin, Fentie, Atalay Mulu, Abiye, Alfoalem Araba

    Published in Risk management and healthcare policy (01-01-2020)
    “…Venous thromboembolism (VTE) is the most common preventable cause of hospitalization-associated mortality. In the absence of optimal prophylaxis and depending…”
    Get full text
    Journal Article
  5. 5

    Enteric-Coated Aspirin and the Risk of Gastrointestinal Side Effects: A Systematic Review by Kedir, Hanan Muzeyin, Sisay, Eskinder Ayalew, Abiye, Alfoalem Araba

    Published in International journal of general medicine (31-08-2021)
    “…Aspirin appeared as a medicine to deal with aches and inflammation, but due to its antiplatelet properties, it has evolved into a drug mainly used to avert…”
    Get full text
    Journal Article